Organ-on-a-Chip: Global Markets

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $5,500	158 Pages	BCC Research	March, 2022	WA17066810

Best Price Guarantee
Price	from $5,500
Length	158 Pages
Publisher	BCC Research
Published Date	March, 2022
SKU	WA17066810

Organ-on-a-Chip: Global Markets

Report Scope:

The scope of this report covers various types of products available in the organ-on-a-chip market and potential application sectors in various industries. The organ-on-a-chip market is broken down into various segments. Revenue forecasts from 2019 to 2026 are given for each type, application, offering and end user. Revenue generated from the installation and maintenance of instruments has been excluded from the report. The application segment is characterized by various types, including drug discovery and development, toxicological research, and physiological model development, and by end-use industry, including academic and research institutes, pharmaceutical and biotechnology companies, cosmetics industry and other end users. By type market is segmented to liver, lung, kidney, heart and others. The report also focuses on regional segmentation of the market.

Further, it explains the major drivers and regional dynamics of the global market and current trends within the industry. It also includes information about the industry structure and competitive landscape as well as the impact of COVID-19 on the market. The report includes detailed profiles of the major players in the global organ-on-a-chip market.

Report Includes:

- 55 data tables and 29 additional tables
- An up-to-date review and analysis of the global markets for organ-on-a-chip within the biotech industry
- Analyses of the global market trends, with data from 2019 to 2021, and projections of compound annual growth rates (CAGRs) through 2026
- Information on multi-channel 3-D microfluidic cell culture chip, and discussion of their ability to imitate human microenvironment in vitro
- Evaluation and forecast the global organ-on-a-chip market size, and corresponding market share analysis by technology offering, organ type, application, end-user vertical and region
- Discussion on how organ-on-a-chip is emerging as a priority testing alternative which is replacing animals in life science research, toxicology testing and drug development studies
- Review of potential applications in pharmaceutical and life science research sectors, including preclinical drugs testing, drug screening, personalized medicine, phenotypic screening, lead optimization and disease modelling
- Insights into the recent industry structure including the government programs and policies in support of organ-on-a-chip and coverage of revised laws involving animal testing
- Review of patent grants for innovations in organ-on-a-chip technology across each major category
- Descriptive company profiles of the leading global players, including 4Dcell, BiomimX, Emulate Inc., Kirkstall Ltd., Nortis and TissUse GmbH

Companies Mentioned

4DCELL
AXOSIM
BEONCHIP
BIOIVT
BIOMIMX
CHERRY BIOTECH
CN BIO
ELVEFLOW
EMULATE INC.
FLUIGENT
HESPEROS INC.
HUREL CORP.
INSPHERO
KIRKSTALL
MESOBIO TECH
MICRONIT
MIMETAS
NORTIS
SYNVIVO
TARA BIOSYSTEMS INC.
TISSUSE GMBH

Chapter 1 Introduction: Study Goals and Objectives; Reasons for Doing This Study; What's New in This Update?; Scope of Report; Information Sources; Methodology; Geographic Breakdown; Analyst's Credentials; BCC Custom Research; Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background: Introduction; Developments in Drug Discovery; 1950-1970; 1970-1990; 1990-2010; 2010 to the Present; Market Potential; Strategic Initiatives; Regulatory Framework; U.S.; European Union; China; Japan
Chapter 4 Market Dynamics: Factors Affecting the Organ-on-a-Chip Market; Market Drivers; Increasing Incidence of Chronic Diseases; Rising Demand for a Way to Enhance the Effectiveness of Clinical Trials; Increasing Investments for Drug Research and Development; Increasing Demand for Personalized Medicine; Market Restraints; Lack of Standardization
Chapter 5 Impact of COVID-19: Introduction; Outbreak Origins; Symptoms of COVID-19; Progression of COVID-19; Incubation Period; Epidemiology; Collaboration Between Organizations and Governments; Spread of Disease; Impact of COVID-19 on the Organ-on-a-Chip Market
Chapter 6 Global Organ-on-a-Chip Market by Type: Liver; Liver-on-a-Chip Classifications Depending on Their Principal Actions; Heart; Kidney; Lung; Other Organs
Chapter 7 Global Organ-on-a-Chip Market by End User: Biotechnology and Pharmaceutical Companies; Cosmetics Industry; Academic and Research Institutes; Increasing R&D Spending; Other End Users
Chapter 8 Global Organ-on-a-Chip Market by Offering: Products; Services
Chapter 9 Global Organ-on-a-Chip Market by Application: Drug Discovery and Development; Toxicological Research; Physiological Model Development
Chapter 10 Global Organ-on-a-Chip Market by Region: North America; U.S.; Canada; Europe; U.K.; France; Germany; Spain; Rest of Europe; Asia-Pacific; China; Japan; India; Australia; Rest of the World
Chapter 11 Industry Structure: Raw Material Suppliers; Quality and Technology; Terms and Conditions; Cost-Effective Components; Manufacturers; Distributors; End Users of Consumables; Competitive Analysis; Patent Landscape; Patent Review by Year; Patent Review by Country
Chapter 12 Company Profiles: 4DCELL; AXOSIM; BEONCHIP; BIOMIMX; BIOIVT; CHERRY BIOTECH; CN BIO; ELVEFLOW; EMULATE INC.; FLUIGENT; HESPEROS INC.; HUREL CORP.; INSPHERO; KIRKSTALL; MESOBIO TECH; MICRONIT; MIMETAS; NORTIS; SYNVIVO; TARA BIOSYSTEMS INC.; TISSUSE GMBH
List of Tables: Summary Table: Global Organ-on-a-Chip Market, Through 2026; Table 1: Drug Development Time Span; Table 2: Advantages of Organ-on-a-Chip Compared to Traditional Methods of Drug Discovery; Table 3: U.S. NIH Funding of Research for Various Diseases, 2014-2020; Table 4: Distribution of COVID-19 Clinical Symptoms; Table 5: COVID-19 Cases, by WHO Region, February 18, 2022; Table 6: Global Organ-on-a-Chip Market, Through 2026; Table 7: Global Organ-on-a-Chip Market, by Type, Through 2026; Table 8: Liver-on-a-Chip Classifications; Table 9: Global Liver Organ-on-a-Chip Market, by Region, Through 2026; Table 10: Global Heart Organ-on-a-Chip Market, by Region, Through 2026; Table 11: Deaths from CVD and Number of People Living with CVD in U.K., 2020; Table 12: Global Kidney Organ-on-a-Chip Market, by Region, Through 2026; Table 13: Global Burden of Chronic Kidney Disease, 2010 and 2019; Table 14: Global Lung Organ-on-a-Chip Market, by Region, Through 2026; Table 15: Mortality Rates Due to Leading Respiratory Causes, 2019; Table 16: Global Market for Other Types of Organ-on-a-Chip, by Region, Through 2026; Table 17: Global Organ-on-a-Chip Market, by End User, Through 2026; Table 18: Global Biotechnology and Pharmaceutical Company Revenues from the Organ-on-a-Chip Market, by Region, Through 2026; Table 19: Biopharmaceuticals R&D Spending, 2010-2024; Table 20: Global Cosmetics Industry Revenues from the Organ-on-a-Chip Market, by Region, Through 2026; Table 21: Global Academic and Research Institution Revenues from the Organ-on-a-Chip Market, by Region, Through 2026; Table 22: Cancer Research Grants, by Cancer Type, August 2021; Table 23: Global Prevalence of Dementia, 2020-2050; Table 24: Global Market for Other End Users of Organ-on-a-Chip, by Region, Through 2026; Table 25: Global Organ-on-a-Chip Market, by Offering, Through 2026; Table 26: Global Organ-on-a-Chip Products Market, by Region, Through 2026; Table 27: Global Organ-on-a-Chip Services Market, by Region, Through 2026; Table 28: Global Organ-on-a-Chip Market, by Application, Through 2026; Table 29: Global Pharmaceutical Market, 2019 and 2020; Table 30: Pharmaceutical Spending as a Percentage of Total Healthcare Spending, by Country, 2019; Table 31: PhRMA Member Company, Global R&D Spending, 2015-2019; Table 32: Medicines in Development, 2018; Table 33: Global Market for Organ-on-a-Chip in Drug Discovery and Development, by Region, Through 2026; Table 34: Global Market for Organ-on-a-Chip in Toxicological Research, by Region, Through 2026; Table 35: Total Number of New Cases and Deaths Due to Various Cancers Globally, 2020; Table 36: Global Market for Organ-on-a-Chip in Physiological Model Development, by Region, Through 2026; Table 37: Global Organ-on-a-Chip Market, by Region, Through 2026; Table 38: North American Organ-on-a-Chip Market, by Type, Through 2026; Table 39: North American Organ-on-a-Chip Market, by Application, Through 2026; Table 40: North American Organ-on-a-Chip Market, by End User, Through 2026; Table 41: North American Organ-on-a-Chip Market, by Offering, Through 2026; Table 42: NIH Spending on Stem Cell Research in the U.S., 2015-2020; Table 43: Shares of the Annual Budget of the Canadian Institutes of Health Research, by Type of Research, 2020; Table 44: European Organ-on-a-Chip Market, by Type, Through 2026; Table 45: European Organ-on-a-Chip Market, by Application, Through 2026; Table 46: European Organ-on-a-Chip Market, by End User, Through 2026; Table 47: European Organ-on-a-Chip Market, by Offering, Through 2026; Table 48: R&D Expenditure in Spain, 2015 and 2019; Table 49: Asia-Pacific Organ-on-a-Chip Market, by Type, Through 2026; Table 50: Asia-Pacific Organ-on-a-Chip Market, by Application, Through 2026; Table 51: Asia-Pacific Organ-on-a-Chip Market, by End User, Through 2026; Table 52: Asia-Pacific Organ-on-a-Chip Market, by Offering, Through 2026; Table 53: R&D Spending, by India’s Top Pharma Companies, 2018; Table 54: Rest of the World Organ-on-a-Chip Market, by Type, Through 2026; Table 55: Rest of the World Organ-on-a-Chip Market, by Application, Through 2026; Table 56: Rest of the World Organ-on-a-Chip Market, by End User, Through 2026; Table 57: Rest of the World Organ-on-a-Chip Market, by Offering, Through 2026; Table 58: Raw Material/Part Manufacturers; Table 59: Competitive Analysis of Organ-on-a-Chip Market, 2020; Table 60: Patent Review of Organ-on-a-Chip, 2018-2021; Table 61: Patent Review of Organ-on-a-Chip, by Country, 2018-2021; Table 62: 4Dcell: Product Portfolio; Table 63: AxoSim Inc.: Product Portfolio; Table 64: BEOnChip: Product Portfolio; Table 65: BiomimX: Product Portfolio; Table 66: BiomimX: Product Pipeline; Table 67: BioIVT: Product Portfolio; Table 68: Cherry Biotech: Product Portfolio; Table 69: CN Bio: Product Portfolio; Table 70: Elveflow: Product Portfolio; Table 71: Emulate Inc.: Product Portfolio; Table 72: Fluigent: Research Product Portfolio; Table 73: Hesperos Inc.: Product Portfolio; Table 74: Hurel Corp.: Product Portfolio; Table 75: InSphero: Product Portfolio; Table 76: Kirkstall Ltd.: Product Portfolio; Table 77: MesoBio Tech: Product Portfolio; Table 78: Micronit: Product Portfolio; Table 79: Mimetas B.V.: Product Portfolio; Table 80: Nortis: Product Portfolio; Table 81: SynVivo: Product Portfolio; Table 82: Tara Biosystems Inc.: Product Portfolio; Table 83: TissUse GmbH: Product Portfolio
List of Figures: Summary Figure: Global Organ-on-a-Chip Market, 2019-2026; Figure 1: Development of Organ-on-a-Chip; Figure 2: Drug Development Process; Figure 3: FDA Stages of New Medicine Review and Regulation; Figure 4: Research and Development Process of a Drug; Figure 5: Global Pharmaceutical R&D Spending, 2010-2019; Figure 6: Personalized Medicines on Market, 2008-2020; Figure 7: Global Organ-on-a-Chip Market, 2019-2026; Figure 8: Global Organ-on-a-Chip Market, by Type, 2019-2026; Figure 9: Global Liver Organ-on-a-Chip Market, by Region, 2019-2026; Figure 10: Global Heart Organ-on-a-Chip Market, by Region, 2019-2026; Figure 11: Share of Heart Disease Deaths in the U.S., by Disease Type, 2021; Figure 12: Global Kidney Organ-on-a-Chip Market, by Region, 2019-2026; Figure 13: Global Lung Organ-on-a-Chip Market, by Region, 2019-2026; Figure 14: Global Market for Other Types of Organ-on-a-Chip, by Region, 2019-2026; Figure 15: Organ-on-a-Chip Market, by End Users; Figure 16: Global Organ-on-a-Chip Market, by End User, 2019-2026; Figure 17: Major Factors Driving the Growth of the Organ-on-a-Chip Market; Figure 18: Global Biotechnology and Pharmaceutical Company Revenues from the Organ-on-a-Chip Market, by Region, 2019-2026; Figure 19: Biopharmaceuticals R&D Spending, 2010-2024; Figure 20: Global Cosmetics Industry Revenues from the Organ-on-a-Chip Market, by Region, 2019-2026; Figure 21: Global Academic and Research Institution Revenues from the Organ-on-a-Chip Market, by Region, 2019-2026; Figure 22: Shares of Global R&D Funding, by Region, 2020; Figure 23: Top Ten Countries’ R&D Expenditures, 2020; Figure 24: Global Market for Other End Users of Organ-on-a-Chip, by Region, 2019-2026; Figure 25: Global Organ-on-a-Chip Market, by Offering, 2019-2026; Figure 26: Key Products: Organ-on-a-Chip; Figure 27: Global Organ-on-a-Chip Products Market, by Region, 2019-2026; Figure 28: Global Organ-on-a-Chip Services Market, by Region, 2019-2026; Figure 29: Global Organ-on-a-Chip Market, by Application, 2019-2026; Figure 30: Global Pharmaceutical Market Shares, by Region, 2020; Figure 31: Pharmaceutical Spending as a Percentage of Total Healthcare Spending, by Country, 2019; Figure 32: PhRMA Member Company, Global R&D Spending, 2015-2019; Figure 33: Global Market for Organ-on-a-Chip in in Drug Discovery and Development, by Region, 2019-2026; Figure 34: Global Market for Organ-on-a-Chip in Toxicological Research, by Region, 2019-2026; Figure 35: Global Prevalence of Cancer, by Type, 2019; Figure 36: Global Market for Organ-on-a-Chip in Physiological Model Development, by Region, 2019-2026; Figure 37: Global Organ-on-a-Chip Market, by Region, 2019-2026; Figure 38: North American Organ-on-a-Chip Market, by Type, 2019-2026; Figure 39: North American Organ-on-a-Chip Market, by Application, 2019-2026; Figure 40: North American Organ-on-a-Chip Market, by End User, 2019-2026; Figure 41: North American Organ-on-a-Chip Market, by Offering, 2019-2026; Figure 42: NIH Spending on Stem Cell Research in the U.S., 2015-2020; Figure 43: Shares of the Annual Budget of the Canadian Institute of Health Research, by Type of Research, 2020; Figure 44: European Organ-on-a-Chip Market, by Type, 2019-2026; Figure 45: European Organ-on-a-Chip Market, by Application, 2019-2026; Figure 46: European Organ-on-a-Chip Market, by End User, 2019-2026; Figure 47: European Organ-on-a-Chip Market, by Offering, 2019-2026; Figure 48: R&D Expenditure in Spain, 2015 and 2019; Figure 49: Asia-Pacific Organ-on-a-Chip Market, by Type, 2019-2026; Figure 50: Asia-Pacific Organ-on-a-Chip Market, by Application, 2019-2026; Figure 51: Asia-Pacific Organ-on-a-Chip Market, by End User, 2019-2026; Figure 52: Asia-Pacific Organ-on-a-Chip Market, by Offering, 2019-2026; Figure 53: R&D Spending, by India’s Top Pharma Companies, 2018; Figure 54: Rest of the World Organ-on-a-Chip Market, by Type, 2019-2026; Figure 55: Rest of the World Organ-on-a-Chip Market, by Application, 2019-2026; Figure 56: Rest of the World Organ-on-a-Chip Market, by End User, 2019-2026; Figure 57: Rest of the World Organ-on-a-Chip Market, by Offering, 2019-2026; Figure 58: Industry Structure of Instruments Used in the Organ-on-a-Chip Market; Figure 59: Patent Shares of Organ-on-a-Chip, by Year, 2018-2021; Figure 60: Patent Review of Organ-on-a-Chip, by Country, 2018-2021